PATUSKY CHRISTOPHER

SEC Form 4 insider trading activity

PATUSKY CHRISTOPHER has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Nov 10, 2026.

On the most recent filing, PATUSKY CHRISTOPHER is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, PATUSKY CHRISTOPHER reported no open-market purchases and 4 open-market sales totaling $3.4M in UTHR. The largest disclosed transaction in the window is a sale of 2,910 UTHR shares on Apr 24, 2026, worth $1.7M.

Companies traded

Other insiders at UTHR

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$3.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
UTHRSale$702KNov 10SEC ↗
UTHRSale$1.7MApr 24SEC ↗
UTHRSale$579KApr 17SEC ↗
UTHRSale$496KDec 16SEC ↗
Showing 1–4 of 4
1 / 1

Frequently asked questions

How many SEC Form 4 filings has PATUSKY CHRISTOPHER made?

PATUSKY CHRISTOPHER has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.

Which companies does PATUSKY CHRISTOPHER trade?

PATUSKY CHRISTOPHER has filed SEC Form 4 disclosures for 1 company, including UTHR.

When was PATUSKY CHRISTOPHER's most recent SEC Form 4 filing?

PATUSKY CHRISTOPHER's most recent SEC Form 4 filing on Tracefour is dated Nov 10, 2026.

What is PATUSKY CHRISTOPHER's total buy and sell value in the current window?

Inside the rolling retention window, PATUSKY CHRISTOPHER bought $0 and sold $3.4M based on SEC Form 4 filings.

What was PATUSKY CHRISTOPHER's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 2,910 UTHR shares on 2026-04-24, worth $1.7M, per SEC Form 4 filings.